Emapalumab (anti-IFNγ)

Ask supplier a question | View on supplier's website

Emapalumab (anti-IFNγ), a monoclonal antibody directed against IFNγ, is the first global approval for the treatment of pediatric and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory.

Supplier	Selleck Chemicals
Product #	A2041
Sku #	A2041-1mg
Pricing	1mg, $259.00

Feedback